These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Gene expression in mixed type liposarcoma. Kim JI; Choi KU; Lee IS; Moon TY; Lee CH; Kim HW; Kim JY; Park DY; Sol MY Pathology; 2006 Apr; 38(2):114-9. PubMed ID: 16581650 [TBL] [Abstract][Full Text] [Related]
45. Co-amplification of 8p12 and 11q13 in breast cancers is not the result of a single genomic event. Paterson AL; Pole JC; Blood KA; Garcia MJ; Cooke SL; Teschendorff AE; Wang Y; Chin SF; Ylstra B; Caldas C; Edwards PA Genes Chromosomes Cancer; 2007 May; 46(5):427-39. PubMed ID: 17285574 [TBL] [Abstract][Full Text] [Related]
47. Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH. Micci F; Teixeira MR; Bjerkehagen B; Heim S Cytogenet Genome Res; 2002; 97(1-2):13-9. PubMed ID: 12438732 [TBL] [Abstract][Full Text] [Related]
48. Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Andre F; Job B; Dessen P; Tordai A; Michiels S; Liedtke C; Richon C; Yan K; Wang B; Vassal G; Delaloge S; Hortobagyi GN; Symmans WF; Lazar V; Pusztai L Clin Cancer Res; 2009 Jan; 15(2):441-51. PubMed ID: 19147748 [TBL] [Abstract][Full Text] [Related]
49. A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. Forus A; Bjerkehagen B; Sirvent N; Meza-Zepeda LA; Coindre JM; Berner JM; Myklebost O; Pedeutour F Cancer Genet Cytogenet; 2001 Nov; 131(1):13-8. PubMed ID: 11734312 [TBL] [Abstract][Full Text] [Related]
50. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Järvinen AK; Autio R; Kilpinen S; Saarela M; Leivo I; Grénman R; Mäkitie AA; Monni O Genes Chromosomes Cancer; 2008 Jun; 47(6):500-9. PubMed ID: 18314910 [TBL] [Abstract][Full Text] [Related]
51. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Forus A; Flørenes VA; Maelandsmo GM; Meltzer PS; Fodstad O; Myklebost O Cell Growth Differ; 1993 Dec; 4(12):1065-70. PubMed ID: 8117620 [TBL] [Abstract][Full Text] [Related]
52. Characterization of a hotspot region on chromosome 12 for amplification in ring chromosomes in atypical lipomatous tumors. Trombetta D; Mertens F; Lonoce A; D'Addabbo P; Rennstam K; Mandahl N; Storlazzi CT Genes Chromosomes Cancer; 2009 Nov; 48(11):993-1001. PubMed ID: 19691106 [TBL] [Abstract][Full Text] [Related]
53. Immunohistochemical, cytogenetic, and molecular cytogenetic characterization of both components of a dedifferentiated liposarcoma: implications for histogenesis. Nishio J; Iwasaki H; Nabeshima K; Naito M Anticancer Res; 2015 Jan; 35(1):345-50. PubMed ID: 25550570 [TBL] [Abstract][Full Text] [Related]
54. p16 Expression in Fat Necrosis: A Potential Diagnostic Pitfall in the Evaluation of Differentiated Adipocytic Neoplasms. Ng W; Messiou C; Smith M; Thway K Int J Surg Pathol; 2015 Oct; 23(7):544-8. PubMed ID: 26173427 [TBL] [Abstract][Full Text] [Related]
55. Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. Forus A; Larramendy ML; Meza-Zepeda LA; Bjerkehagen B; Godager LH; Dahlberg AB; Saeter G; Knuutila S; Myklebost O Cancer Genet Cytogenet; 2001 Mar; 125(2):100-11. PubMed ID: 11369052 [TBL] [Abstract][Full Text] [Related]
56. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes. Schraders M; Jares P; Bea S; Schoenmakers EF; van Krieken JH; Campo E; Groenen PJ Br J Haematol; 2008 Oct; 143(2):210-21. PubMed ID: 18699851 [TBL] [Abstract][Full Text] [Related]
57. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets. Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848 [TBL] [Abstract][Full Text] [Related]
58. AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes. Zatkova A; Merk S; Wendehack M; Bilban M; Muzik EM; Muradyan A; Haferlach C; Haferlach T; Wimmer K; Fonatsch C; Ullmann R Genes Chromosomes Cancer; 2009 Jun; 48(6):510-20. PubMed ID: 19306356 [TBL] [Abstract][Full Text] [Related]
59. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223 [TBL] [Abstract][Full Text] [Related]
60. Silence of chromosomal amplifications in colon cancer. Platzer P; Upender MB; Wilson K; Willis J; Lutterbaugh J; Nosrati A; Willson JK; Mack D; Ried T; Markowitz S Cancer Res; 2002 Feb; 62(4):1134-8. PubMed ID: 11861394 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]